Announcement of Jianfeng Group Lin2017 -008 on Providing Guarantee to Holding Subsidists
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2017-008
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd.
Providing Guarantees to Holding Subsidiaries
The board of directors and all directors of the company guarantee that the content of this announcement does not contain any False records, misleading statements or major omissions, and bear individual and joint responsibility for the authenticity, accuracy and completeness of its contents .
Important Content Tips
● Names of Guarantees: Zhejiang Jianfeng Pharmaceutical Co., Ltd., Daye Jianfeng Cement Co., Ltd., Zhejiang Jianfeng International Trade Co., Ltd.
● Proposed guarantee amount: set guarantee amount 4.3 .9 billion yuan.
● Is there any counter-guarantee in this guarantee: No
● Cumulative number of overdue external guarantees: No
Overview of 1. guarantees
2017 On April 15, 39, Zhejiang Jianfeng Group Co., Ltd. held the 11th meeting of the 9th Board of Directors, and all eight directors of the company attended the meeting in person; comply with the relevant provisions of the "Company Law" and the "Articles of Association" of the company, and the resolutions made are legal and valid. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the "Proposal on Providing Guarantees for Holding Subsidiaries" was reviewed and passed with 8 votes in favor, 0 votes against, and 0 abstentions.
This motion needs to be submitted to the general meeting of shareholders for consideration.Basic Information of 2. Guarantees
1
, Zhejiang Jianfeng Pharmaceutical Co., Ltd., with a registered capital of 19853 yuan, of which: the company accounts for 99.16 percent, and its registered address is the second floor of X02 Office Quality Inspection Building, No. 58 Gaofan Section, Baitang Downline, Wucheng District, Jinhua City, Zhejiang Province. Its main business is drug research and development and production (operated with valid licenses); import raw materials for production and scientific research; import machinery and equipment, instruments and spare parts. (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments).
2, daye peak cement co., ltd. has a registered capital of 2.5 .1 billion yuan, of which the company accounts for 6% and the company's holding subsidiary Zhejiang peak cement co., ltd. (the company holds 95.25) accounts for 70%. registered address: daye city hubei province security town; main business: cement, cement clinker, cement mechanical and electrical equipment manufacturing and sales; building materials products such as sales.
3, Zhejiang Jianfeng International Trade Co., Ltd., with a registered capital of 3000 yuan, of which: 93.33 of our company and 6.67 of Jianfeng Pharmaceutical Co., Ltd., registered address: 88 changchun West Road, Jindong Economic Development Zone, Zhejiang Province, mainly engaged in self-management and agency of import and export of various commodities and technologies, engaged in processing of imported materials and "three to one supplement" business; To carry out countertrade and re-export trade, warehousing of bonded and general goods (except dangerous goods), pharmaceutical intermediates, pharmaceutical equipment, etc.
Audited keyfinancial data of the above subsidiaries 2016 (in: ten thousand yuan)
| company name |
total assets |
total liabilities |
total bank loans |
total current liabilities |
net assets |
total operating income |
net profit attributable to parent company owner |
| daye peak cement co., ltd. |
52910.68 |
13875.37 |
13803.94 |
39035.31 |
48836.56 |
5273.45 |
|
| Zhejiang Jianfeng Pharmaceutical Co., Ltd. |
107327.91 |
64705.62 |
3400 |
58149.59 |
42622.29 |
122399.97 |
4528.59 |
| Zhejiang Jianfeng International Trading Co., Ltd. |
6537.97 |
5285.42 |
0 |
5172.92 |
1252.55 |
15089.31 |
169.39 |
1
, to Holding Subsidiary provide guarantees for loans from financial institutions, set the following limits:
| Guaranteed Unit |
Set Guarantee Limit (RMB 10,000) |
| Daye Jianfeng Cement Co., Ltd. |
5000 |
| Zhejiang Jianfeng Pharmaceutical Co., Ltd. |
30000 |
| Zhejiang Jianfeng International Trade Co., Ltd. |
8000 |
| Total |
43000 |
, agreed to be Zhejiang Jianfeng International Trade Co., Ltd. Letter of Guarantee from the Company, provide corresponding guarantee for the goods stored in the company by the customers of Zhejiang Jianfeng International Trade Co., Ltd.
The guarantee within the above amount is authorized to be executed by the chairman of the board of directors.4. the opinion of the board of directors
The above guaranteed companies are all controlling subsidiaries of the company. The company can effectively control the guarantee risks, and the board of directors agrees to the above guarantees.
# The three independent directors of the 296 company issued independent opinions on the matter and believed that the formation of the resolution complied with the "Company Law", the company's "Articles of Association" and other relevant provisions, and did not harm the interests of small and medium shareholders.
5. Cumulative Number of External Guarantees and Number of Overdue Guarantees
As of the disclosure date of this announcement, the total amount of external guarantees approved by the company and its controlling subsidiaries is 12.5
.3 billion yuan, accounting for 52.4 of the total owner's equity attributable to the parent company by the audited consolidated caliber at the end of 2016. Among them, the total amount of approved guarantee for the controlling subsidiary is 650 million yuan, accounting for 27.25 of the total owner's equity attributable to the parent company's audited consolidated caliber at the end of 2016.As of the disclosure date of this announcement, the actual balance of external guarantees of the company and its controlling subsidiaries (excluding subsidiaries) was 5.77
.6 billion yuan, accounting for 24.17 of the total owner's equity attributable to the parent company by the audited merger at the end of 2016. The actual balance of the company's guarantee to the controlling subsidiary is 25 million yuan, accounting for 1.05 of the Company's total audited consolidated equity attributable to owners of the parent company at the end of 2016.As of the disclosure date of this announcement, the company has no overdue guarantee.
6. Reference Document Catalogue
Resolution of the 11th
Meeting of the 9th Board of Directors of the Company;
hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
April 18, 2017
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page